Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils

Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils
复制标题

DOI:
10.1189/jlb.0313137
复制
发表时间:
2013-10-01
影响因子:
5.5
通讯作者:
Katz, Steven C.
Katz, Steven C.
中科院分区:
医学3区
文献类型:
--
作者:
Licata, Lauren A.;Nguyen, Cang T.;Katz, Steven C.

文献摘要

被引文献

相似文献

胆道梗阻是一种常见的临床问题,与肝内炎症和免疫功能受损有关。众所周知,PD-1介导T细胞功能障碍,但据报道,在各种损伤模型中,PD-1可促进和减轻急性炎症。通过建立小鼠BDL模型,我们研究了肝内PD-1表达对LTC功能、炎症和胆汁淤积的影响。BDL后,LTCs中PD-1表达显著升高。BDL后PD-1表达增加与LTC增殖减少和ifn - γ产生减少有关。消除PD-1的表达导致BDL后LTC的增殖能力显著提高,此外还有更多的免疫刺激细胞因子谱。PD-1(-/-)小鼠不仅LTC功能恢复,而且与BDL后的WT动物相比,胆道细胞损伤、胆汁淤积和炎症程度也明显减轻。pd -1介导的BDL后急性炎症与肝内中性粒细胞和Th17细胞群的扩增有关,后者依赖于IL-6。PD-1阻断是一种有吸引力的策略,可以逆转肝内免疫抑制,同时限制炎症性肝损伤。
Biliary obstruction is a common clinical problem that is associated with intrahepatic inflammation and impaired immunity. PD-1 is well known to mediate T cell dysfunction but has been reported to promote and attenuate acute inflammation in various injury models. With the use of a well-established murine model of BDL, we studied the effects of intrahepatic PD-1 expression on LTC function, inflammation, and cholestasis. Following BDL, PD-1 expression increased significantly among LTCs. Increased PD-1 expression following BDL was associated with decreased LTC proliferation and less IFN-gamma production. Elimination of PD-1 expression resulted in significantly improved proliferative capacity among LTC following BDL, in addition to a more immunostimulatory cytokine profile. Not only was LTC function rescued in PD-1(-/-) mice, but also, the degrees of biliary cell injury, cholestasis, and inflammation were diminished significantly compared with WT animals following BDL. PD-1-mediated acute inflammation following BDL was associated with expansions of intrahepatic neutrophil and Th17 cell populations, with the latter dependent on IL-6. PD-1 blockade represents an attractive strategy for reversing intrahepatic immunosuppression while limiting inflammatory liver damage.